Product Details

Tagrisso 80mg Tablet contains Osimertinib, a targeted cancer therapy used in the treatment of non-small cell lung cancer (NSCLC) that has specific mutations in the epidermal growth factor receptor (EGFR). Osimertinib is an EGFR tyrosine kinase inhibitor (TKI) that works by blocking the activity of the mutated EGFR, which drives the growth and spread of cancer cells. It is particularly effective against NSCLC that has developed resistance to other EGFR inhibitors.